JP2022545765A5 - - Google Patents

Info

Publication number
JP2022545765A5
JP2022545765A5 JP2021577965A JP2021577965A JP2022545765A5 JP 2022545765 A5 JP2022545765 A5 JP 2022545765A5 JP 2021577965 A JP2021577965 A JP 2021577965A JP 2021577965 A JP2021577965 A JP 2021577965A JP 2022545765 A5 JP2022545765 A5 JP 2022545765A5
Authority
JP
Japan
Prior art keywords
amino acids
sequence
peptide
amino acid
region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021577965A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022545765A (ja
JP7663881B2 (ja
Filing date
Publication date
Priority claimed from EP19382537.9A external-priority patent/EP3756680A1/en
Application filed filed Critical
Publication of JP2022545765A publication Critical patent/JP2022545765A/ja
Publication of JP2022545765A5 publication Critical patent/JP2022545765A5/ja
Application granted granted Critical
Publication of JP7663881B2 publication Critical patent/JP7663881B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021577965A 2019-06-26 2020-06-26 中間径フィラメント由来ペプチドおよびその使用 Active JP7663881B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19382537.9A EP3756680A1 (en) 2019-06-26 2019-06-26 Intermediate filament-derived peptides and their uses
EP19382537.9 2019-06-26
PCT/EP2020/068052 WO2020260603A1 (en) 2019-06-26 2020-06-26 Intermediate filament-derived peptides and their uses

Publications (3)

Publication Number Publication Date
JP2022545765A JP2022545765A (ja) 2022-10-31
JP2022545765A5 true JP2022545765A5 (https=) 2023-06-27
JP7663881B2 JP7663881B2 (ja) 2025-04-17

Family

ID=67211651

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021577965A Active JP7663881B2 (ja) 2019-06-26 2020-06-26 中間径フィラメント由来ペプチドおよびその使用

Country Status (4)

Country Link
US (1) US20220251158A1 (https=)
EP (2) EP3756680A1 (https=)
JP (1) JP7663881B2 (https=)
WO (1) WO2020260603A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4656207A1 (en) 2024-05-30 2025-12-03 Fundació Hospital Universitari Vall Hebron - Institut de Recerca In vitro method for transducing a target cell

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000506385A (ja) * 1996-02-20 2000-05-30 スミスクライン・ビーチャム・コーポレイション 新規ｅｒａ
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
DE112004002217B4 (de) * 2003-11-19 2017-04-06 Tokyo University Of Science Foundation Proteinbildungskomplex mit einem c-Jun-Protein, Nucleinsäure, codierend denselben und Verfahren unter Verwendung desselben
DE602004019180D1 (de) * 2004-03-16 2009-03-12 Centre Nat Rech Scient Methode zur Identifizierung von unbekannten Proteinen mittels zwei-dimensionaler Auftrennung und Verwendung von Markern
CN101160524A (zh) * 2005-02-24 2008-04-09 西米尼斯公司 用于生物样品分类的组合物和方法
SI22865A (sl) * 2008-09-25 2010-03-31 Univerza@V@Ljubljani Peptid uroaktivin kot aktivator encima urokinaze
WO2017176385A1 (en) * 2016-04-08 2017-10-12 La Jolla Institute For Allergy And Immunology Compositions and methods for diagnosing and treating brain injury
WO2019051103A1 (en) * 2017-09-06 2019-03-14 Lawrence Livermore National Security, Llc METHODS AND SYSTEMS FOR EXECUTING GENETICALLY MODIFIED PROTEIN ANALYSIS, AND ASSOCIATED MARKER PROTEIN GENETIC VARIATIONS AND DATABASES

Similar Documents

Publication Publication Date Title
US11229694B2 (en) Vaccine against RSV
US10442845B2 (en) Interferon analogs
US6399053B1 (en) Methods of enhancing bioactivity of chemokines
ES2359616T3 (es) Péptidos citotóxicos modificados por restos voluminosos o lipofílicos.
ES2185595T5 (es) Peptidos antivirales modificados y sus composiciones para la prevencion y/o el tratamiento de infecciones viricas.
US6235716B1 (en) Multivalent ligands which modulate angiogenesis
JP2020517260A5 (https=)
JP2023503472A5 (https=)
AU2008286026B2 (en) Synthetic pulmonary surfactant peptides
JP2022545765A5 (https=)
ES2349153T3 (es) Inhibidores del virus de la hepatitis c.
IL276359B1 (en) Methods and compositions for inhibiting adam 9 biological activities
CA2190972A1 (en) Compositions of transactivating proteins of human immunodeficiency virus
US5587457A (en) Neutrophil stimulating peptides
JP2021531246A5 (https=)
CN100577685C (zh) 长效胸腺素α1的聚乙二醇化修饰物
CN112029000A (zh) 鸭干扰素α融合蛋白在制备抗鸭1型肝炎病毒的药物中的用途
Raju et al. Substrate analog inhibitors of HIV-1 protease containing phenylnorstatine as a transition state element
CN111978414A (zh) 鸭干扰素γ融合蛋白在制备防治鸭病毒性肝炎药物中的用途
JP2023527048A5 (https=)
RU2020122291A (ru) Слитый белок, включающий белок il-2 и белок cd80, и его применение
JPH02502905A (ja) 粘膜による吸収を高める、ソルビン及び誘導ペプチド
JPH09507838A (ja) 二重鎖血液調節ペプチド
JPH08512310A (ja) ペプチド化合物
JP2023520990A5 (https=)